Ceramidases are a group of enzymes that catalyze the hydrolysis of ceramide, dihydroceramide, and phytoceramide into sphingosine (SPH), dihydrosphingosine (DHS), and phytosphingosine (PHS), respectively, along with a free fatty acid. Ceramide catabolism is controlled by ceramidases that are pivotal in the pathophysiology of these diseases of altered lipid homeostasis such as Alzheimer’s disease, type 2 diabetes-induced insulin resistance, cancer, and cardiovascular diseases. Ceramidases are classified into the acid, neutral, and alkaline ceramidase subtypes according to the pH optima for their catalytic activity.
货号 | 产品名 | Cas | 产品描述 |
---|---|---|---|
PC15325 | ARN14974 | 1644158-57-5 | 酸性神经酰胺酶抑制剂,ARN14974 is a benzoxazolone carboxamide inhibitor of acid ceramidase (IC50 = 79 nM). |
PC15087 | Ceranib 1 | 328076-61-5 | 神经酰胺酶抑制剂,Ceranib1 是一种神经酰胺酶 (ceramidase) 抑制剂。Ceranib1 能抑制细胞神经酰胺酶对外源性神经酰胺类似物的活性,诱导多种神经酰胺物质的积累,降低鞘氨醇和 S1P 水平。Ceranib1 能抑制细胞卵巢癌细胞增殖。 |
PC15330 | Ceranib-2 | 1402830-75-4 | 细胞神经酰胺酶活性抑制剂,Ceranib-2 是一种有效的非脂质神经酰胺酶 (ceramidase) 抑制剂,可在 SKOV3 细胞中抑制细胞神经酰胺酶活性,IC50 为 28 μM。Ceranib-2 可诱导多种神经酰胺物质的积累,降低鞘氨醇和鞘氨醇1-磷酸 (S1P) 的水平,并诱导细胞凋亡 (apoptosis)。抗癌活性。 |
PC15376 | D-NMAPPD | 35922-06-6 | 神经酰胺酶抑制剂,诱导细胞凋亡,NMT1 inhibitor B13 (LCL4) is a myristoylCoA analog that acts as a small molecule inhibitor of NMT1 with IC50 of 77.6 uM, blocks Src myristoylation and Src localization to the cytoplasmic membrane. |